【日本】22nd Meeting of the Novel Coronavirus Response Headquarters

On March 23, 2020, the Prime Minister held the 22nd meeting of the Novel Coronavirus Response Headquarters at the Diet.

At the meeting, a discussion was held on the response to the novel coronavirus (COVID-19).

Based on the discussion, the Prime Minister said,

We are seeing the novel coronavirus disease (COVID-19) spreading globally, as the number of new cases rapidly increases in countries overseas, including in Europe and the United States. Even in the United States, the number of cases across the whole country exceeds 30,000 and infections are spreading
In response, the U.S. Department of State has raised the travel advisory worldwide to Level 4 on March 19 (local time), and requested all U.S. citizens to avoid all international travel. It has also advised all U.S. nationals currently abroad to return to the U.S. Furthermore, on March 21 (local time), the Centers for Disease Control and Prevention raised the Travel Health Notice for five countries, including Japan, to Level 3, recommending that travelers avoid all nonessential travel, and is asking all those travelling from those countries to self-quarantine for 14 days.
In line with these major border controls measures by the U.S., we raised the Travel Advice and Warning on Infectious Diseases for the United States to Level 2 yesterday, and request Japanese citizens to avoid all non-essential travel there.
Along with this measure, in order to align our measures efforts being made overseas, including in the United States, to prevent further spread of infections worldwide, we will request individuals entering Japan from all parts of the United States, including Japanese nationals, to stay for 14 days at a place designated by the Quarantine Station Chief, and not to use public transportation. We will implement this measure from 0:00 a.m., March 26, until the end of April, for the time being.
We will continue implementing responsive border controls without hesitation, let alone domestic preventive measures, such as counter-cluster measures, as we monitor and analyse the current infection situation in other countries. I ask the relevant ministers to respond to the situation, while maintaining a strong sense of crisis.”


資料來源:Prime Minister of Japan and His Cabinet http://japan.kantei.go.jp/98_abe/actions/202003/_00033.html

最新文章

查看全部

【台灣】國內累計443人確診,427人解除隔離

中央流行疫情指揮中心今(1)日表示,國內昨(31)日新增237例新型冠狀病毒肺炎相關通報,截至目前累計通報72,319例(含71,287例排除),其中443例確診(今日新增案443),分別為352例境外移入,55例本土病例及36例敦睦艦隊。確診個案中7人死亡,427人解除隔離,其餘持續住院隔離中。 指揮中心指出,全球累計6,195,424例確診,分布於187個國家/地區;病例數以美國1,817,7

【台灣】建立健康安全防護網,持續優化科技智慧防疫

中央流行疫情指揮中心今(1)日表示,科技防疫在本次國內COVID-19(武漢肺炎)疫情防治扮演極為重要的角色,我國在疫情初期,即以超前部署的概念,規劃可能需要的防疫作為,從邊境管制到社區管理,建置多項智慧防疫系統及訂定「實聯制措施指引」,多方面保護民眾的健康及隱私。 指揮中心指出,我國智慧防疫系統包括「入境檢疫系統」,從旅客入境健康聲明即開始彙整相關資料,並拋轉至「防疫追蹤系統」,提供第一線民、警

【台灣】國衛院新冠病毒快篩試劑 非專屬授權技轉成果說明

國家衛生研究院(國衛院)與國防醫學院預防醫學研究所(國防醫學院預醫所)共同合作之「新型冠狀病毒快篩試劑」已於4月8日舉辦非專屬授權技術說明會,逾20家國內快篩試劑相關廠商共同與會,並陸續收到十多家具相關生產製造經驗之廠商投件申請。其中,有多家廠商採取策略聯盟的方式遞件申請,透過結合上、中、下游的力量,包含抗體生產、試劑製造到臨床試驗等重要環節,期盼藉由運用所屬技術優勢發揮加乘效果,以利快速完成快篩

版權所有 教育商城 |  TaiDa International Education Services

Copyright© 2020 All Rights Reserved.

本網頁各連結標題及連結內容歸原權利人所有 /  未經書面允許 不得轉載或節錄引用